Teleflex (NYSE:TFX) Posts Earnings Results, Beats Expectations By $0.03 EPS

Teleflex (NYSE:TFX) issued its quarterly earnings data on Thursday. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03, Zacks reports. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Stock Down 21.8 %

Shares of Teleflex stock opened at $138.99 on Friday. The company has a 50-day simple moving average of $176.35 and a two-hundred day simple moving average of $205.70. Teleflex has a 52-week low of $135.95 and a 52-week high of $249.90. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a market capitalization of $6.46 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 1.73 and a beta of 1.16.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.98%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on TFX. Truist Financial decreased their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday. Mizuho decreased their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and dropped their target price for the company from $220.00 to $155.00 in a report on Friday. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $207.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.